| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000018825 |
| Receipt No. | R000021775 |
| Official scientific title of the study | Efficacy of flurbiprofen axetil as add-on therapy for postoperative pain after Total Knee Arthroplasty |
| Date of disclosure of the study information | 2015/09/01 |
| Last modified on | 2017/02/12 (Ver. 7) |
| Basic information | ||
| Official scientific title of the study | Efficacy of flurbiprofen axetil as add-on therapy for postoperative pain after Total Knee Arthroplasty | |
| Title of the study (Brief title) | Efficacy of flurbiprofen axetil as add-on therapy for postoperative pain after Total Knee Arthroplasty | |
| Region |
|
|
| Condition | ||
| Condition | postoperative pain after Total Knee Arthroplasty (TKA) | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Investigate efficacy of flurbirprofen axetil as add-on therapy for postoperative pain control after TKA |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | - pain score (during rest and during exercise)
- other additional medication for postoperative pain |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Single blind -participants are blinded |
| Control | Active |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | |
| Blocking | NO |
| Concealment | Numbered container method |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Administer flurbiprofen axetil after TKA | |
| Interventions/Control_2 | Not administer flurbiprofen axetil after TKA | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | Patient who (is) / whose;
1) provides written informed consent. 2) over 65 year-old female 3) plans to have TKA for the first time at our hospital 4) is to be applied Vanguard RP type (BIOMET company) 5) FT(Femoral Tibial) angle is 180-190; before operation 6) HKA (Hip Knee Ankle) correction angle is less than 20; 7) Kellgren-Lawrence classification is grade 2-3 |
|||
| Key exclusion criteria | Patient who (is);
1) has disease that influences on the assessment of this study 2) considered difficult to perform assessment of this study by investigator. 3) has contraindications for medicine used in this study. 4) judged inappropriate for this study by investigator. |
|||
| Target sample size | 40 | |||
| Research contact person | |
| Name of lead principal investigator | Koji Yamaguchi |
| Organization | SOUSEIKAI Nishi-Kumamoto Hospital |
| Division name | Orthopedics |
| Address | 1012 KOGA, TOMIAI-MACHI, MINAMI-KU, KUMAMOTO 861-4157, JAPAN |
| TEL | 096-358-1118 |
| kouji-yamaguchi@nishikuma.com | |
| Public contact | |
| Name of contact person | Daisuke Hashimoto |
| Organization | SOUSEIKAI Nishi-Kumamoto Hospital |
| Division name | Nursing Department |
| Address | 1012 KOGA, TOMIAI-MACHI, MINAMI-KU, KUMAMOTO 861-4157, JAPAN |
| TEL | 096-358-1118 |
| Homepage URL | |
| nk-kansen@nishikuma.com | |
| Sponsor | |
| Institute | SOUSEIKAI Nishi-Kumamoto Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 医療法人相生会 にしくまもと病院(熊本県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | Efficacy of flurbiprofen axetil as add-on therapy for postoperative pain after Total Knee Arthroplasty was not observed (The 47th annual meeting of Japanese Society for Replacement Arthroplasty) |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021775 |